Showing 9,481 - 9,500 results of 18,522 for search 'significantly ((((((less decrease) OR (we decrease))) OR (mean decrease))) OR (a decrease))', query time: 0.64s Refine Results
  1. 9481

    Supplementary file 2_The interventional effect of astragaloside IV on rodent models of myocardial fibrosis: a systematic review and meta-analysis.doc by Haozhe Li (6399116)

    Published 2025
    “…However, it exerted no significant impact on the levels of LVIDs and LVIDd in the model.…”
  2. 9482

    Table 1_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. …”
  3. 9483

    Image 2_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. …”
  4. 9484

    Table 2_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. …”
  5. 9485

    Image 1_A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy.pdf by Pei Zhang (232846)

    Published 2025
    “…In January 2024, everolimus therapy was started, resulting in a partial response by April 2024, with a significant reduction in liver metastases. …”
  6. 9486

    Table1_Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients.xlsx by Mei Yang (51996)

    Published 2024
    “…Background<p>Significant individual differences exist in the clinical manifestations of thyroid-associated ophthalmopathy (TAO). …”
  7. 9487

    Table 2_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.xlsx by Xianyu Dai (18939514)

    Published 2025
    “…The median age among these cases was 65 years, with males comprising 53.4%. There were significant annual increases in UR reports associated with antineoplastic agents (0.19% per year) and antidiabetic drugs (0.09% per year), while reports linked to bronchodilators decreased (−0.53% per year). …”
  8. 9488

    Table 1_Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.docx by Xianyu Dai (18939514)

    Published 2025
    “…The median age among these cases was 65 years, with males comprising 53.4%. There were significant annual increases in UR reports associated with antineoplastic agents (0.19% per year) and antidiabetic drugs (0.09% per year), while reports linked to bronchodilators decreased (−0.53% per year). …”
  9. 9489

    Image 2_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.pdf by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  10. 9490

    Image 1_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.tif by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  11. 9491

    Table 2_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.docx by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  12. 9492

    Table 1_A comprehensive study of hip dislocation: global health burden from 1990 to 2021 and its predictions to 2030.docx by Xu Zheng (296676)

    Published 2025
    “…</p>Conclusion<p>The disease burden of hip dislocation remains a significant public health challenge. Data-driven analysis is pivotal for guiding clinical practice, shaping public health policies, and ensuring optimal allocation of healthcare resources. …”
  13. 9493

    DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
  14. 9494

    Data_Sheet_2_Causal relationship between non-alcoholic fatty liver disease and sarcopenia: a bidirectional Mendelian randomization study.PDF by Meng Chen (48769)

    Published 2024
    “…In the reverse MR study, weight median analysis showed that NAFLD caused a decrease in ALM (OR = 0.953, 95%CI 0.957–0.994, p = 0.001); whereas NAFLD showed no correlation with usual walking pace or grip strength (all with p > 0.05). …”
  15. 9495

    Data_Sheet_1_Causal relationship between non-alcoholic fatty liver disease and sarcopenia: a bidirectional Mendelian randomization study.PDF by Meng Chen (48769)

    Published 2024
    “…In the reverse MR study, weight median analysis showed that NAFLD caused a decrease in ALM (OR = 0.953, 95%CI 0.957–0.994, p = 0.001); whereas NAFLD showed no correlation with usual walking pace or grip strength (all with p > 0.05). …”
  16. 9496

    Data Sheet 1_Development of a colloidal gold-based immunochromatographic strip for rapid detection of Areca palm velarivirus 1.docx by Jie Lu (139953)

    Published 2025
    “…Background<p>Areca palm velarivirus 1 (APV1), the causal agent of betel palm yellow leaf disease (YLD), has caused significant yield losses and decreased product quality of betel nuts, posing a serious economic threat to local farmers. …”
  17. 9497

    Prediction performance of each model. by Ahmed S. Alkhalifah (20721713)

    Published 2025
    “…</p><p>Results</p><p>Out of 23,106 admissions, 2,338 met the criteria. Nonsurvivors had a significantly higher time-weighted average MP (TWA-MP) than survivors. …”
  18. 9498

    Patient inclusion flow chart. by Ahmed S. Alkhalifah (20721713)

    Published 2025
    “…</p><p>Results</p><p>Out of 23,106 admissions, 2,338 met the criteria. Nonsurvivors had a significantly higher time-weighted average MP (TWA-MP) than survivors. …”
  19. 9499

    Data Sheet 1_Microbial and molecular signatures for enhanced gut health in pigs fed a diet with spray-dried plasma as functional protein source.docx by Soumya K. Kar (4600924)

    Published 2025
    “…We report a significant (P < 0.05) decrease in the relative abundance of the Sarcina genera in the small intestine, an effect comparable to pharmaceutical concentrations of zinc oxide (ZnO). …”
  20. 9500

    Data Sheet 1_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.docx by Daiping Li (5007932)

    Published 2025
    “…The results with pre-diabetes patients suggest significant decreases in postprandial glucose (MD -12.76, 95% CI -16.78, -8.74; N = 2), HbA1c (MD -0.37, 95% CI -0.56, -0.18; N = 2), and the homeostatic model assessment index (HOMA index) (MD -0.24, 95% CI -0.37, -0.11; N = 2), though further research is needed to confirm these findings. …”